How to Amend Tax Return Online: Pharma Tariffs Impact
Pharmaceutical tariffs could quietly raise out-of-pocket drug costs and slow medical innovation. This guide explains ...
Pharmaceuticals
This tag page gathers 4 Pharmaceuticals articles covering stock moves, earnings previews, and dip-buys to help you evaluate pharma equities and manage risk.
19 articles
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Down 25%, Should Bristol Be a Dip Buy Right Now Today?
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
Bausch Health (BHC) 2025: Q4 Earnings Preview for Investors
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
One Reason Lilly Stock Never Sell: A Long-Term Investor’s Cornerstone
If you’re seeking a single, enduring reason to own Lilly stock, this article lays it out. You’ll learn how a durable ...
XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...